# STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection

> **NCT07120490** · NA · NOT_YET_RECRUITING · sponsor: **Medical University of Warsaw** · enrollment: 424 (estimated)

## Conditions studied

- Clostridioides Difficile Infection
- Clostridioides Difficile Infection Recurrence
- Fecal Microbiota Transplantation (FMT)
- Comparative Effectiveness of CDI Treatments
- Fidaxomicin
- Vancomycin

## Interventions

- **OTHER:** FMT (fecal microbiota transplantation)
- **DRUG:** Fidaxomicin
- **DRUG:** Vancomycin (VAN) treatment

## Key facts

- **NCT ID:** NCT07120490
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 424 (ESTIMATED)
- **Last updated:** 2025-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07120490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07120490, "STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07120490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*